Cargando…
Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironments
Radiotherapy as an anti-tumor treatment can stimulate the immune system. However, irradiated tumor cells express CD47 to escape the anti-tumor immune response. Anti- CD47 Immunotherapy is a possible way to tackle this problem. This study evaluated the effect of single high dose radiotherapy combined...
Autores principales: | Rostami, Elham, Bakhshandeh, Mohsen, Ghaffari-Nazari, Haniyeh, Alinezhad, Maedeh, Alimohammadi, Masoumeh, Alimohammadi, Reza, Mahmoodi Chalbatani, Ghanbar, Hejazi, Ehsan, Webster, Thomas J., Tavakkol-Afshari, Jalil, Jalali, Seyed Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417014/ https://www.ncbi.nlm.nih.gov/pubmed/36018888 http://dx.doi.org/10.1371/journal.pone.0273547 |
Ejemplares similares
-
Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model
por: Alimohammadi, Reza, et al.
Publicado: (2023) -
Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice
por: Ghaffari-Nazari, Haniyeh, et al.
Publicado: (2015) -
Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy
por: Alimohammadi, Reza, et al.
Publicado: (2020) -
Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response
por: Alinezhad, Maedeh, et al.
Publicado: (2020) -
The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2020)